Tradename | Company | Number | Date | Products |
---|---|---|---|---|
STERANE | Pfizer | N-009996 DISCN | 1982-01-01 | 1 products |
DELTA-CORTEF | Pharmacia & Upjohn | N-009987 DISCN | 1982-01-01 | 1 products |
METI-DERM | Merck & Co | N-010209 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ORAPRED ODT | ADVANZ PHARMA | N-021959 RX | 2006-06-01 | 3 products, RLD, RS |
PEDIAPRED | Seton Pharmaceuticals | N-019157 RX | 1986-05-28 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BLEPHAMIDE | Allergan | N-012813 DISCN | 1982-01-01 | 1 products, RLD |
METIMYD | Merck & Co | N-010210 DISCN | 1982-01-01 | 2 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NEO-HYDELTRASOL | Merck & Co | N-050378 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
blephamide | New Drug Application | 2013-11-15 |
cambison | unapproved drug other | 2018-12-06 |
desowen | ANDA, New Drug Application | 2019-01-28 |
econopred | 2006-09-11 | |
ixoba m | unapproved drug other | 2021-11-03 |
orapred | New Drug Application | 2024-12-05 |
pediapred | New Drug Application | 2024-02-01 |
pred forte | New Drug Application | 2024-02-29 |
pred mild | New Drug Application | 2024-02-29 |
pred phos - brom | unapproved drug other | 2018-06-08 |
Expiration | Code | ||
---|---|---|---|
PREDNISOLONE, PREDNISOLONE, AUROBINDO PHARMA LTD | |||
2023-11-18 | CGT |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Prednisolone Acetate, Flo-Pred, Taro | |||
7799331 | 2028-10-11 | DP | U-139, U-1068 |
Code | Description |
---|---|
J1020 | Injection, methylprednisolone acetate, 20 mg |
J1030 | Injection, methylprednisolone acetate, 40 mg |
J1040 | Injection, methylprednisolone acetate, 80 mg |
J2650 | Injection, prednisolone acetate, up to 1 ml |
J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg |
J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg |
J7509 | Methylprednisolone oral, per 4 mg |
J7510 | Prednisolone oral, per 5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 4 | 5 | 1 | — | — | 6 |
Follicular lymphoma | D008224 | — | C82 | 2 | 2 | 1 | — | — | 3 |
Arteritis | D001167 | EFO_0009011 | I77.6 | — | — | 1 | — | — | 1 |
Takayasu arteritis | D013625 | EFO_1001857 | M31.4 | — | — | 1 | — | — | 1 |
Aortic arch syndromes | D001015 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 4 | — | — | — | 4 |
B-cell lymphoma | D016393 | — | — | 4 | 4 | — | — | — | 4 |
Leukemia | D007938 | — | C95 | 2 | 1 | — | — | — | 2 |
Recurrence | D012008 | — | — | 1 | 1 | — | — | — | 2 |
Lymphoid leukemia | D007945 | — | C91 | 2 | 1 | — | — | — | 2 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 2 | 2 | — | — | — | 2 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 2 | 2 | — | — | — | 2 |
B-cell lymphoma marginal zone | D018442 | — | C88.4 | 1 | 1 | — | — | — | 1 |
Reactive arthritis | D016918 | EFO_0007460 | M02.3 | 1 | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | — | 1 | — | — | — | — | 1 |
Acute disease | D000208 | — | — | 1 | — | — | — | — | 1 |
Philadelphia chromosome | D010677 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Prednisolone |
INN | prednisolone |
Description | Prednisolone is a glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone. It has a role as an adrenergic agent, an anti-inflammatory drug, an antineoplastic agent, an immunosuppressive agent, a drug metabolite, an environmental contaminant and a xenobiotic. It is a glucocorticoid, an 11beta-hydroxy steroid, a 21-hydroxy steroid, a 17alpha-hydroxy steroid, a 20-oxo steroid, a 3-oxo-Delta(1),Delta(4)-steroid, a primary alpha-hydroxy ketone, a tertiary alpha-hydroxy ketone and a C21-steroid. It is functionally related to a Delta(1)-progesterone. |
Classification | Small molecule |
Drug class | steroids (not prednisolone derivatives); prednisone and prednisolone derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO |
PDB | — |
CAS-ID | 50-24-8 |
RxCUI | — |
ChEMBL ID | CHEMBL131 |
ChEBI ID | 8378 |
PubChem CID | 5755 |
DrugBank | DB00860 |
UNII ID | 9PHQ9Y1OLM (ChemIDplus, GSRS) |